Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Common-variant associations with fragile X syndrome.

Crowley JJ, Szatkiewicz J, Kähler AK, Giusti-Rodriguez P, Ancalade N, Booker JK, Carr JL, Crawford GE, Losh M, Stockmeier CA, Taylor AK, Piven J, Sullivan PF.

Mol Psychiatry. 2018 Dec 7. doi: 10.1038/s41380-018-0290-3. [Epub ahead of print]

PMID:
30531935
2.

Altered Expression of Phox2 Transcription Factors in the Locus Coeruleus in Major Depressive Disorder Mimicked by Chronic Stress and Corticosterone Treatment In Vivo and In Vitro.

Fan Y, Chen P, Raza MU, Szebeni A, Szebeni K, Ordway GA, Stockmeier CA, Zhu MY.

Neuroscience. 2018 Nov 21;393:123-137. doi: 10.1016/j.neuroscience.2018.09.038. Epub 2018 Oct 11.

PMID:
30315878
3.

Risk-taking behaviors and stressors differentially predict suicidal preparation, non-fatal suicide attempts, and suicide deaths.

Athey A, Overholser J, Bagge C, Dieter L, Vallender E, Stockmeier CA.

Psychiatry Res. 2018 Dec;270:160-167. doi: 10.1016/j.psychres.2018.09.032. Epub 2018 Sep 15.

PMID:
30253320
4.

A Novel Alternative Splicing Mechanism That Enhances Human 5-HT1A Receptor RNA Stability Is Altered in Major Depression.

Le François B, Zhang L, Mahajan GJ, Stockmeier CA, Friedman E, Albert PR.

J Neurosci. 2018 Sep 19;38(38):8200-8210. doi: 10.1523/JNEUROSCI.0902-18.2018. Epub 2018 Aug 7.

PMID:
30093565
5.

Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia.

Bryois J, Garrett ME, Song L, Safi A, Giusti-Rodriguez P, Johnson GD, Shieh AW, Buil A, Fullard JF, Roussos P, Sklar P, Akbarian S, Haroutunian V, Stockmeier CA, Wray GA, White KP, Liu C, Reddy TE, Ashley-Koch A, Sullivan PF, Crawford GE.

Nat Commun. 2018 Aug 7;9(1):3121. doi: 10.1038/s41467-018-05379-y.

6.

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.

Wray NR, Ripke S, Mattheisen M, Trzaskowski M, Byrne EM, Abdellaoui A, Adams MJ, Agerbo E, Air TM, Andlauer TMF, Bacanu SA, Bækvad-Hansen M, Beekman AFT, Bigdeli TB, Binder EB, Blackwood DRH, Bryois J, Buttenschøn HN, Bybjerg-Grauholm J, Cai N, Castelao E, Christensen JH, Clarke TK, Coleman JIR, Colodro-Conde L, Couvy-Duchesne B, Craddock N, Crawford GE, Crowley CA, Dashti HS, Davies G, Deary IJ, Degenhardt F, Derks EM, Direk N, Dolan CV, Dunn EC, Eley TC, Eriksson N, Escott-Price V, Kiadeh FHF, Finucane HK, Forstner AJ, Frank J, Gaspar HA, Gill M, Giusti-Rodríguez P, Goes FS, Gordon SD, Grove J, Hall LS, Hannon E, Hansen CS, Hansen TF, Herms S, Hickie IB, Hoffmann P, Homuth G, Horn C, Hottenga JJ, Hougaard DM, Hu M, Hyde CL, Ising M, Jansen R, Jin F, Jorgenson E, Knowles JA, Kohane IS, Kraft J, Kretzschmar WW, Krogh J, Kutalik Z, Lane JM, Li Y, Li Y, Lind PA, Liu X, Lu L, MacIntyre DJ, MacKinnon DF, Maier RM, Maier W, Marchini J, Mbarek H, McGrath P, McGuffin P, Medland SE, Mehta D, Middeldorp CM, Mihailov E, Milaneschi Y, Milani L, Mill J, Mondimore FM, Montgomery GW, Mostafavi S, Mullins N, Nauck M, Ng B, Nivard MG, Nyholt DR, O'Reilly PF, Oskarsson H, Owen MJ, Painter JN, Pedersen CB, Pedersen MG, Peterson RE, Pettersson E, Peyrot WJ, Pistis G, Posthuma D, Purcell SM, Quiroz JA, Qvist P, Rice JP, Riley BP, Rivera M, Saeed Mirza S, Saxena R, Schoevers R, Schulte EC, Shen L, Shi J, Shyn SI, Sigurdsson E, Sinnamon GBC, Smit JH, Smith DJ, Stefansson H, Steinberg S, Stockmeier CA, Streit F, Strohmaier J, Tansey KE, Teismann H, Teumer A, Thompson W, Thomson PA, Thorgeirsson TE, Tian C, Traylor M, Treutlein J, Trubetskoy V, Uitterlinden AG, Umbricht D, Van der Auwera S, van Hemert AM, Viktorin A, Visscher PM, Wang Y, Webb BT, Weinsheimer SM, Wellmann J, Willemsen G, Witt SH, Wu Y, Xi HS, Yang J, Zhang F; eQTLGen; 23andMe, Arolt V, Baune BT, Berger K, Boomsma DI, Cichon S, Dannlowski U, de Geus ECJ, DePaulo JR, Domenici E, Domschke K, Esko T, Grabe HJ, Hamilton SP, Hayward C, Heath AC, Hinds DA, Kendler KS, Kloiber S, Lewis G, Li QS, Lucae S, Madden PFA, Magnusson PK, Martin NG, McIntosh AM, Metspalu A, Mors O, Mortensen PB, Müller-Myhsok B, Nordentoft M, Nöthen MM, O'Donovan MC, Paciga SA, Pedersen NL, Penninx BWJH, Perlis RH, Porteous DJ, Potash JB, Preisig M, Rietschel M, Schaefer C, Schulze TG, Smoller JW, Stefansson K, Tiemeier H, Uher R, Völzke H, Weissman MM, Werge T, Winslow AR, Lewis CM, Levinson DF, Breen G, Børglum AD, Sullivan PF; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium.

Nat Genet. 2018 May;50(5):668-681. doi: 10.1038/s41588-018-0090-3. Epub 2018 Apr 26.

7.

Astrocyte pathology in the ventral prefrontal white matter in depression.

Rajkowska G, Legutko B, Moulana M, Syed M, Romero DG, Stockmeier CA, Miguel-Hidalgo JJ.

J Psychiatr Res. 2018 Jul;102:150-158. doi: 10.1016/j.jpsychires.2018.04.005. Epub 2018 Apr 7.

PMID:
29660602
8.

Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder.

Mahajan GJ, Vallender EJ, Garrett MR, Challagundla L, Overholser JC, Jurjus G, Dieter L, Syed M, Romero DG, Benghuzzi H, Stockmeier CA.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:177-186. doi: 10.1016/j.pnpbp.2017.11.017. Epub 2017 Nov 22.

PMID:
29175309
9.

MicroRNA-21: Expression in oligodendrocytes and correlation with low myelin mRNAs in depression and alcoholism.

Miguel-Hidalgo JJ, Hall KO, Bonner H, Roller AM, Syed M, Park CJ, Ball JP, Rothenberg ME, Stockmeier CA, Romero DG.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):503-514. doi: 10.1016/j.pnpbp.2017.08.009. Epub 2017 Aug 9.

10.

Length of axons expressing the serotonin transporter in orbitofrontal cortex is lower with age in depression.

Rajkowska G, Mahajan G, Legutko B, Challagundla L, Griswold M, Albert PR, Daigle M, Miguel-Hidalgo JJ, Austin MC, Blakely RD, Steffens DC, Stockmeier CA.

Neuroscience. 2017 Sep 17;359:30-39. doi: 10.1016/j.neuroscience.2017.07.006. Epub 2017 Jul 13.

11.

Elevated DNA Oxidation and DNA Repair Enzyme Expression in Brain White Matter in Major Depressive Disorder.

Szebeni A, Szebeni K, DiPeri TP, Johnson LA, Stockmeier CA, Crawford JD, Chandley MJ, Hernandez LJ, Burgess KC, Brown RW, Ordway GA.

Int J Neuropsychopharmacol. 2017 May 1;20(5):363-373. doi: 10.1093/ijnp/pyw114.

12.

Opioid precursor protein isoform is targeted to the cell nuclei in the human brain.

Kononenko O, Bazov I, Watanabe H, Gerashchenko G, Dyachok O, Verbeek DS, Alkass K, Druid H, Andersson M, Mulder J, Svenningsen ÅF, Rajkowska G, Stockmeier CA, Krishtal O, Yakovleva T, Bakalkin G.

Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):246-255. doi: 10.1016/j.bbagen.2016.11.002. Epub 2016 Nov 10.

13.

Up-Regulation of PKR Signaling Pathway by Ethanol Displays an Age of Onset-Dependent Relationship.

Duncan JW, Johnson S, Zhang X, Zheng B, Luo J, Ou XM, Stockmeier CA, Wang JM.

Alcohol Clin Exp Res. 2016 Nov;40(11):2320-2328. doi: 10.1111/acer.13209. Epub 2016 Sep 20.

14.

Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims.

Rafalo-Ulinska A, Piotrowska J, Kryczyk A, Opoka W, Sowa-Kucma M, Misztak P, Rajkowska G, Stockmeier CA, Datka W, Nowak G, Szewczyk B.

J Psychiatr Res. 2016 Dec;83:220-229. doi: 10.1016/j.jpsychires.2016.09.008. Epub 2016 Sep 13.

15.

The functional serotonin 1a receptor promoter polymorphism, rs6295, is associated with psychiatric illness and differences in transcription.

Donaldson ZR, le Francois B, Santos TL, Almli LM, Boldrini M, Champagne FA, Arango V, Mann JJ, Stockmeier CA, Galfalvy H, Albert PR, Ressler KJ, Hen R.

Transl Psychiatry. 2016 Mar 1;6:e746. doi: 10.1038/tp.2015.226.

16.

Differential effect of lithium on cell number in the hippocampus and prefrontal cortex in adult mice: a stereological study.

Rajkowska G, Clarke G, Mahajan G, Licht CM, van de Werd HJ, Yuan P, Stockmeier CA, Manji HK, Uylings HB.

Bipolar Disord. 2016 Feb;18(1):41-51. doi: 10.1111/bdi.12364. Epub 2016 Feb 4.

17.

Binge ethanol exposure increases the Krüppel-like factor 11-monoamine oxidase (MAO) pathway in rats: Examining the use of MAO inhibitors to prevent ethanol-induced brain injury.

Duncan JW, Zhang X, Wang N, Johnson S, Harris S, Udemgba C, Ou XM, Youdim MB, Stockmeier CA, Wang JM.

Neuropharmacology. 2016 Jun;105:329-340. doi: 10.1016/j.neuropharm.2016.01.024. Epub 2016 Jan 22.

18.

Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.

Cobb JA, O'Neill K, Milner J, Mahajan GJ, Lawrence TJ, May WL, Miguel-Hidalgo J, Rajkowska G, Stockmeier CA.

Neuroscience. 2016 Mar 1;316:209-20. doi: 10.1016/j.neuroscience.2015.12.044. Epub 2015 Dec 30.

19.

Attenuation of social interaction-associated ultrasonic vocalizations and spatial working memory performance in rats exposed to chronic unpredictable stress.

Riaz MS, Bohlen MO, Gunter BW, Quentin H, Stockmeier CA, Paul IA.

Physiol Behav. 2015 Dec 1;152(Pt A):128-134. doi: 10.1016/j.physbeh.2015.09.005. Epub 2015 Sep 11.

20.

AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors.

Tuan EW, Horti AG, Olson TT, Gao Y, Stockmeier CA, Al-Muhtasib N, Bowman Dalley C, Lewin AE, Wolfe BB, Sahibzada N, Xiao Y, Kellar KJ.

Mol Pharmacol. 2015 Oct;88(4):640-9. doi: 10.1124/mol.115.099978. Epub 2015 Jul 10.

21.

Oligodendrocyte morphometry and expression of myelin - Related mRNA in ventral prefrontal white matter in major depressive disorder.

Rajkowska G, Mahajan G, Maciag D, Sathyanesan M, Iyo AH, Moulana M, Kyle PB, Woolverton WL, Miguel-Hidalgo JJ, Stockmeier CA, Newton SS.

J Psychiatr Res. 2015 Jun;65:53-62. doi: 10.1016/j.jpsychires.2015.04.010. Epub 2015 Apr 20.

22.

Chronic Social Stress and Ethanol Increase Expression of KLF11, a Cell Death Mediator, in Rat Brain.

Duncan J, Wang N, Zhang X, Johnson S, Harris S, Zheng B, Zhang Q, Rajkowska G, Miguel-Hidalgo JJ, Sittman D, Ou XM, Stockmeier CA, Wang JM.

Neurotox Res. 2015 Jul;28(1):18-31. doi: 10.1007/s12640-015-9524-1. Epub 2015 Mar 5.

23.

The IFNγ-PKR pathway in the prefrontal cortex reactions to chronic excessive alcohol use.

Johnson S, Duncan J, Hussain SA, Chen G, Luo J, Mclaurin C, May W, Rajkowska G, Ou XM, Stockmeier CA, Wang JM.

Alcohol Clin Exp Res. 2015 Mar;39(3):476-84. doi: 10.1111/acer.12650. Epub 2015 Feb 19.

24.

Evidence revealing deregulation of the KLF11-MAO A pathway in association with chronic stress and depressive disorders.

Harris S, Johnson S, Duncan JW, Udemgba C, Meyer JH, Albert PR, Lomberk G, Urrutia R, Ou XM, Stockmeier CA, Wang JM.

Neuropsychopharmacology. 2015 May;40(6):1373-82. doi: 10.1038/npp.2014.321. Epub 2014 Dec 15.

25.

Markers of apoptosis induction and proliferation in the orbitofrontal cortex in alcohol dependence.

Whittom A, Villarreal A, Soni M, Owusu-Duku B, Meshram A, Rajkowska G, Stockmeier CA, Miguel-Hidalgo JJ.

Alcohol Clin Exp Res. 2014 Nov;38(11):2790-9. doi: 10.1111/acer.12559.

26.

Basolateral amygdala volume and cell numbers in major depressive disorder: a postmortem stereological study.

Rubinow MJ, Mahajan G, May W, Overholser JC, Jurjus GJ, Dieter L, Herbst N, Steffens DC, Miguel-Hidalgo JJ, Rajkowska G, Stockmeier CA.

Brain Struct Funct. 2016 Jan;221(1):171-84. doi: 10.1007/s00429-014-0900-z. Epub 2014 Oct 7.

27.

BICC1 expression is elevated in depressed subjects and contributes to depressive behavior in rodents.

Ota KT, Andres W, Lewis DA, Stockmeier CA, Duman RS.

Neuropsychopharmacology. 2015 Feb;40(3):711-8. doi: 10.1038/npp.2014.227. Epub 2014 Sep 2.

28.

Shortened telomere length in white matter oligodendrocytes in major depression: potential role of oxidative stress.

Szebeni A, Szebeni K, DiPeri T, Chandley MJ, Crawford JD, Stockmeier CA, Ordway GA.

Int J Neuropsychopharmacol. 2014 Oct;17(10):1579-89. doi: 10.1017/S1461145714000698. Epub 2014 Jun 26.

PMID:
24967945
29.

Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression.

Chandley MJ, Szebeni A, Szebeni K, Crawford JD, Stockmeier CA, Turecki G, Kostrzewa RM, Ordway GA.

Int J Neuropsychopharmacol. 2014 Oct;17(10):1569-78. doi: 10.1017/S1461145714000662. Epub 2014 Jun 13.

PMID:
24925192
30.

Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression.

Miguel-Hidalgo JJ, Wilson BA, Hussain S, Meshram A, Rajkowska G, Stockmeier CA.

J Psychiatr Res. 2014 Aug;55:101-9. doi: 10.1016/j.jpsychires.2014.04.007. Epub 2014 Apr 16.

31.

REDD1 is essential for stress-induced synaptic loss and depressive behavior.

Ota KT, Liu RJ, Voleti B, Maldonado-Aviles JG, Duric V, Iwata M, Dutheil S, Duman C, Boikess S, Lewis DA, Stockmeier CA, DiLeone RJ, Rex C, Aghajanian GK, Duman RS.

Nat Med. 2014 May;20(5):531-5. doi: 10.1038/nm.3513. Epub 2014 Apr 13.

32.

Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder.

Miguel-Hidalgo JJ, Whittom A, Villarreal A, Soni M, Meshram A, Pickett JC, Rajkowska G, Stockmeier CA.

J Affect Disord. 2014 Apr;158:62-70. doi: 10.1016/j.jad.2014.02.010. Epub 2014 Feb 10.

33.

The expression of KLF11 (TIEG2), a monoamine oxidase B transcriptional activator in the prefrontal cortex of human alcohol dependence.

Udemgba C, Johnson S, Stockmeier CA, Luo J, Albert PR, Wang J, May WL, Rajkowska G, Harris S, Sittman DB, Ou XM.

Alcohol Clin Exp Res. 2014 Jan;38(1):144-51. doi: 10.1111/acer.12229. Epub 2013 Aug 5.

34.

Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

Rajkowska G, Stockmeier CA.

Curr Drug Targets. 2013 Oct;14(11):1225-36. Review.

35.

Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder.

Chandley MJ, Szebeni K, Szebeni A, Crawford J, Stockmeier CA, Turecki G, Miguel-Hidalgo JJ, Ordway GA.

J Psychiatry Neurosci. 2013 Jul;38(4):276-84. doi: 10.1503/jpn.120110.

36.

Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.

Goswami DB, Jernigan CS, Chandran A, Iyo AH, May WL, Austin MC, Stockmeier CA, Karolewicz B.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:126-33. doi: 10.1016/j.pnpbp.2012.12.010. Epub 2012 Dec 20.

37.

Morphometric analysis of vascular pathology in the orbitofrontal cortex of older subjects with major depression.

Miguel-Hidalgo JJ, Jiang W, Konick L, Overholser JC, Jurjus GJ, Stockmeier CA, Steffens DC, Krishnan KR, Rajkowska G.

Int J Geriatr Psychiatry. 2013 Sep;28(9):959-70. doi: 10.1002/gps.3911. Epub 2012 Dec 3.

38.

Hippocampal volume and total cell numbers in major depressive disorder.

Cobb JA, Simpson J, Mahajan GJ, Overholser JC, Jurjus GJ, Dieter L, Herbst N, May W, Rajkowska G, Stockmeier CA.

J Psychiatr Res. 2013 Mar;47(3):299-306. doi: 10.1016/j.jpsychires.2012.10.020. Epub 2012 Nov 30.

39.

Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder.

Rajkowska G, Hughes J, Stockmeier CA, Javier Miguel-Hidalgo J, Maciag D.

Biol Psychiatry. 2013 Apr 1;73(7):613-21. doi: 10.1016/j.biopsych.2012.09.024. Epub 2012 Nov 10.

40.

Quantitative analysis of focused a-to-I RNA editing sites by ultra-high-throughput sequencing in psychiatric disorders.

Zhu H, Urban DJ, Blashka J, McPheeters MT, Kroeze WK, Mieczkowski P, Overholser JC, Jurjus GJ, Dieter L, Mahajan GJ, Rajkowska G, Wang Z, Sullivan PF, Stockmeier CA, Roth BL.

PLoS One. 2012;7(8):e43227. doi: 10.1371/journal.pone.0043227. Epub 2012 Aug 17.

41.

Decreased expression of synapse-related genes and loss of synapses in major depressive disorder.

Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A, Majik MS, Jeong LS, Banasr M, Son H, Duman RS.

Nat Med. 2012 Sep;18(9):1413-7.

42.

Mechanistic role for a novel glucocorticoid-KLF11 (TIEG2) protein pathway in stress-induced monoamine oxidase A expression.

Grunewald M, Johnson S, Lu D, Wang Z, Lomberk G, Albert PR, Stockmeier CA, Meyer JH, Urrutia R, Miczek KA, Austin MC, Wang J, Paul IA, Woolverton WL, Seo S, Sittman DB, Ou XM.

J Biol Chem. 2012 Jul 13;287(29):24195-206. doi: 10.1074/jbc.M112.373936. Epub 2012 May 24.

43.

Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects.

Duric V, Banasr M, Stockmeier CA, Simen AA, Newton SS, Overholser JC, Jurjus GJ, Dieter L, Duman RS.

Int J Neuropsychopharmacol. 2013 Feb;16(1):69-82. doi: 10.1017/S1461145712000016. Epub 2012 Feb 17.

44.

Low gene expression of bone morphogenetic protein 7 in brainstem astrocytes in major depression.

Ordway GA, Szebeni A, Chandley MJ, Stockmeier CA, Xiang L, Newton SS, Turecki G, Duffourc MM, Zhu MY, Zhu H, Szebeni K.

Int J Neuropsychopharmacol. 2012 Aug;15(7):855-68. doi: 10.1017/S1461145711001350. Epub 2011 Sep 6.

PMID:
21896235
45.

5-HTTLPR genotype and gender, but not chronic fluoxetine administration, are associated with cortical TREK1 protein expression in rhesus macaques.

Bogdan R, Fitzgibbon H, Woolverton WL, Bethea CL, Iyo AH, Stockmeier CA, Kyle PB, Austin MC.

Neurosci Lett. 2011 Oct 3;503(2):83-6. doi: 10.1016/j.neulet.2011.08.005. Epub 2011 Aug 17.

46.

The reduction of R1, a novel repressor protein for monoamine oxidase A, in major depressive disorder.

Johnson S, Stockmeier CA, Meyer JH, Austin MC, Albert PR, Wang J, May WL, Rajkowska G, Overholser JC, Jurjus G, Dieter L, Johnson C, Sittman DB, Ou XM.

Neuropsychopharmacology. 2011 Sep;36(10):2139-48. doi: 10.1038/npp.2011.105. Epub 2011 Jun 8.

47.

The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder.

Jernigan CS, Goswami DB, Austin MC, Iyo AH, Chandran A, Stockmeier CA, Karolewicz B.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1774-9. doi: 10.1016/j.pnpbp.2011.05.010. Epub 2011 May 23.

48.

Vascular and extravascular immunoreactivity for intercellular adhesion molecule 1 in the orbitofrontal cortex of subjects with major depression: age-dependent changes.

Miguel-Hidalgo JJ, Overholser JC, Jurjus GJ, Meltzer HY, Dieter L, Konick L, Stockmeier CA, Rajkowska G.

J Affect Disord. 2011 Aug;132(3):422-31. doi: 10.1016/j.jad.2011.03.052. Epub 2011 May 4.

49.

Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.

Deschwanden A, Karolewicz B, Feyissa AM, Treyer V, Ametamey SM, Johayem A, Burger C, Auberson YP, Sovago J, Stockmeier CA, Buck A, Hasler G.

Am J Psychiatry. 2011 Jul;168(7):727-34. doi: 10.1176/appi.ajp.2011.09111607. Epub 2011 Apr 15.

50.

A negative regulator of MAP kinase causes depressive behavior.

Duric V, Banasr M, Licznerski P, Schmidt HD, Stockmeier CA, Simen AA, Newton SS, Duman RS.

Nat Med. 2010 Nov;16(11):1328-32. doi: 10.1038/nm.2219. Epub 2010 Oct 17.

Supplemental Content

Loading ...
Support Center